Paper8201642
A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of the prostate.
Smith JA. J Urol, 1994. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of the prostate. Papers, record 8201642. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8201642
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Clonidine | Major topic |
| Diethylstilbestrol | Major topic |
| Ergotamine | Major topic |
| Flushing | Major topic |
| Megestrol | Major topic |
| Phenobarbital | Major topic |
| Prostatic Neoplasms | Major topic |
| Aged | |
| Androgen Antagonists | |
| Gonadotropin-Releasing Hormone | |
| Humans | |
| Male | |
| Megestrol Acetate | |
| Orchiectomy |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42542970 | Treatment of Hot Flashes in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy. | Prostate | 2026 | https://conductscience.org/library/papers/42542970 | PubMed |
| 31367069 | The resurgence of estrogens in the treatment of castration-resistant prostate cancer. | Indian J Urol | 2019 | https://conductscience.org/library/papers/31367069 | PubMed |
| 29928703 | Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results from a single institution experience. | Clin Transl Radiat Oncol | 2018 | https://conductscience.org/library/papers/29928703 | PubMed |
| 26648754 | Optimal delivery of male breast cancer follow-up care: improving outcomes. | Breast Cancer (Dove Med Press) | 2015 | https://conductscience.org/library/papers/26648754 | PubMed |
| 24864213 | Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer. | Prostate Cancer | 2014 | https://conductscience.org/library/papers/24864213 | PubMed |
| 22286861 | Androgen deprivation therapy-associated vasomotor symptoms. | Asian J Androl | 2012 | https://conductscience.org/library/papers/22286861 | PubMed |
| 20494414 | Acupuncture for hot flashes in patients with prostate cancer. | Urology | 2010 | https://conductscience.org/library/papers/20494414 | PubMed |
| 18231613 | Estrogenic side effects of androgen deprivation therapy. | Rev Urol | 2007 | https://conductscience.org/library/papers/18231613 | PubMed |
| 16985883 | Adverse events associated with hormonal therapy for prostate cancer. | Rev Urol | 2005 | https://conductscience.org/library/papers/16985883 | PubMed |
| 15869726 | Preventing and treating the complications of hormone therapy. | Curr Urol Rep | 2005 | https://conductscience.org/library/papers/15869726 | PubMed |
| 11057778 | 'Hot flush', an unpleasant symptom accompanying antiandrogen therapy of prostatic cancer and its treatment by cyproterone acetate. | Int Urol Nephrol | 2000 | https://conductscience.org/library/papers/11057778 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8201642
GET https://conductscience.org/api/papers/v1/8201642/authors